The Foundation for the National Institutes of Health Announces Selection of Eight Rare Diseases for the Bespoke Gene Therapy Consortium Clinical Trial Portfolio

NORTH BETHESDA, MD, May 16, 2023 – Today, the Foundation for the National Institutes of Health (FNIH) announces the Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC) has selected eight rare diseases for its clinical trial portfolio. This portfolio pioneers a novel…#northbethesda #fnih #nih #fda #bgtc #juliegerberding #adeno #aav #terrypirovolakis #elpidatherapeutics
Source: Reuters: Health - Category: Consumer Health News Source Type: news